Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Drugs of Today (Barcelona, Spain : 1998)
|
June 23, 2015
Daclatasvir for the treatment of chronic hepatitis C virus infection
Z Temesgen, S A Rizza
Drugs of Today (Barcelona, Spain : 1998)
|
November 10, 2017
Sofosbuvir/ledipasvir fixed-dose combination for treatment of chronic hepatitis C virus infection in children
S A Rizza, V Nehra, Z Temesgen
Drugs of Today (Barcelona, Spain : 1998)
|
July 2, 2014
Sofosbuvir for the treatment of chronic hepatitis C virus infection
Z Temesgen, R Talwani, S A Rizza
Drugs of Today (Barcelona, Spain : 1998)
|
August 10, 2018
Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection in adults
V Nehra, S A Rizza, Z Temesgen
Drugs of Today (Barcelona, Spain : 1998)
|
May 28, 2019
Dolutegravir plus lamivudine dual therapy - a new option for initial antiretroviral therapy
M Fida, S A Rizza, Z Temesgen
Drugs of Today (Barcelona, Spain : 1998)
|
February 14, 2014
Dolutegravir, an HIV integrase inhibitor for the treatment of HIV infection
Z Temesgen, R Talwani, S A Rizza
Drugs of Today (Barcelona, Spain : 1998)
|
April 28, 2017
Sofosbuvir/velpatasvir fixed-dose combination for the treatment of chronic hepatitis C virus infection
V Nehra, S A Rizza, Z Temesgen
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
April 16, 2013
Leg weakness in a lung transplant patient
T Moua, S A Rizza, C C Kennedy
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
|
November 15, 2019
Sharing the spotlight in Durban: A report from IAS TB2016 at AIDS2016
J A Whitaker, J Sunstrum, S A Rizza
Drugs of Today (Barcelona, Spain : 1998)
|
February 12, 2019
Ibalizumab for the treatment of multidrug-resistant HIV-1 infection
S A Rizza, R Bhatia, J Zeuli, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Drugs of Today (Barcelona, Spain : 1998)
|
June 23, 2015
Daclatasvir for the treatment of chronic hepatitis C virus infection
Z Temesgen, S A Rizza
Drugs of Today (Barcelona, Spain : 1998)
|
November 10, 2017
Sofosbuvir/ledipasvir fixed-dose combination for treatment of chronic hepatitis C virus infection in children
S A Rizza, V Nehra, Z Temesgen
Drugs of Today (Barcelona, Spain : 1998)
|
July 2, 2014
Sofosbuvir for the treatment of chronic hepatitis C virus infection
Z Temesgen, R Talwani, S A Rizza
Drugs of Today (Barcelona, Spain : 1998)
|
August 10, 2018
Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection in adults
V Nehra, S A Rizza, Z Temesgen
Drugs of Today (Barcelona, Spain : 1998)
|
May 28, 2019
Dolutegravir plus lamivudine dual therapy - a new option for initial antiretroviral therapy
M Fida, S A Rizza, Z Temesgen
Drugs of Today (Barcelona, Spain : 1998)
|
February 14, 2014
Dolutegravir, an HIV integrase inhibitor for the treatment of HIV infection
Z Temesgen, R Talwani, S A Rizza
Drugs of Today (Barcelona, Spain : 1998)
|
April 28, 2017
Sofosbuvir/velpatasvir fixed-dose combination for the treatment of chronic hepatitis C virus infection
V Nehra, S A Rizza, Z Temesgen
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
April 16, 2013
Leg weakness in a lung transplant patient
T Moua, S A Rizza, C C Kennedy
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
|
November 15, 2019
Sharing the spotlight in Durban: A report from IAS TB2016 at AIDS2016
J A Whitaker, J Sunstrum, S A Rizza
Drugs of Today (Barcelona, Spain : 1998)
|
February 12, 2019
Ibalizumab for the treatment of multidrug-resistant HIV-1 infection
S A Rizza, R Bhatia, J Zeuli, et al.
Page
of 2